Concepedia

Antonia Busse

AB

Statistics

Publications

32

Citations

1.3K

H-Index

20

Active since

1999

Affiliations

Charité - Universitätsmedizin Berlin(Current)

Franklin University

Heidelberg University

Humboldt-Universität zu Berlin

Freie Universität Berlin

Antonia Busse is an author at Charité - Universitätsmedizin Berlin specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

1999–2024

32

Publications

32

A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS

Ulrich Keilholz, Anne Letsch, Antonia Busse et al. · Blood · 2009 · 299 citations · Full text

Activated SUMOylation restricts MHC class I antigen presentation to confer immune evasion in cancer

Uta M. Demel, Marlitt Böger, Schayan Yousefian et al. · Journal of Clinical Investigation · 2022 · 75 citations · Full text

, , +16

Expression of the Stem Cell Markers Nestin and CD133 on Circulating Melanoma Cells

Alberto Fusi, Uta Reichelt, Antonia Busse et al. · Journal of Investigative Dermatology · 2010 · 74 citations

, , +8

Circulating Tumor Cells as Prognostic Factor for Distant Metastases and Survival in Patients with Primary Uveal Melanoma

R. Schuster, Nikolaos E. Bechrakis, Andrea Stroux et al. · Clinical Cancer Research · 2007 · 71 citations · Full text

Sensitivity of tumor cells to proteasome inhibitors is associated with expression levels and composition of proteasome subunits

Antonia Busse, Marianne Kraus, Il‐Kang Na et al. · Cancer · 2008 · 64 citations

1–5 of 32